UK markets open in 4 hours 11 minutes
NIKKEI 225
33,339.26 +563.44 (+1.72%) HANG SENG
16,415.31 +87.45 (+0.54%) CRUDE OIL
72.39 +0.07 (+0.10%) GOLD FUTURES
2,039.80 +3.50 (+0.17%) DOW
36,124.56 -79.88 (-0.22%) Bitcoin GBP
34,704.48 +1,594.84 (+4.82%)
Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 23.99 |
| Open | 23.83 |
| Bid | 21.61 x 800 |
| Ask | 24.34 x 800 |
| Day's range | 22.85 - 23.84 |
| 52-week range | 14.21 - 37.75 |
| Volume | |
| Avg. volume | 392,088 |
| Market cap | 641.652M |
| Beta (5Y monthly) | 2.58 |
| PE ratio (TTM) | 6.40 |
| EPS (TTM) | 3.59 |
| Earnings date | 14 Nov 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 56.31 |
Business WireArcturus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, December 04, 2023--Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that Joseph Payne, President & Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, on Tuesday, January 9, 2024, at 3:00 p.m.
ZacksThe Zacks Analyst Blog Highlights Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie
Avidity, Bristol Myers Squibb, Vertex, Arcturus and BioVie are included in this Analyst Blog.
ZacksBiotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More
Regulatory and pipeline updates from Avidity Biosciences, Inc. (RNA) and BioVie (BIVI) are in the spotlight this week.
© 2023 Yahoo. All rights reserved.